Potential Retinoid-X-Receptor Agonists: Novel Bexarotene Analogs

Medicine & Life Sciences

• Bexarotene 100%
• Retinoid X Receptors 83%
• Alzheimer Disease 11%
• Neurodegenerative Diseases 8%
• Parkinson Disease 8%
• Schizophrenia 8%
• Inventors 8%
• Triglycerides 8%
• Deficiency Diseases 7%
• Therapeutics 6%
• Cutaneous T-Cell Lymphoma 6%
• Retinoic Acid Receptors 6%
• Retinoids 5%
• Nuclear Family 5%
• Apolipoproteins E 5%
• Drug Discovery 5%
• Cytoplasmic and Nuclear Receptors 5%
• Hypothyroidism 5%
• Microglia 5%
• Hyperlipidemias 5%
• Neoplasms 4%
• Amyloid 4%
• Psychotic Disorders 4%
• Astrocytes 4%
• Dopamine 4%
• Thyroid Gland 4%
• Therapeutic Uses 4%
• Colon 4%
• Breast 3%
• Transcription Factors 3%
• Type 2 Diabetes Mellitus 3%
• Poisons 3%
• Research Personnel 3%
• Depression 3%
• Lipids 3%
• Gene Expression 3%
• Skin 2%
• Lung 2%
• Animals 2%
• Brain 2%